A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors by Feng Gao, Qiaoping Xu, Yingjun Jiang, Bingjun Lu

Get full text

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer by Lanqi Ren, Ning Ren, Yu Zheng, Yibei Yang, Qiaoping Xu

Get full text

Cuproptosis: a promising new target for breast cancer therapy by Qianqian Jiang, Fei Tong, Yun Xu, Cheng Liu, Qiaoping Xu

Get full text

Cost-effectiveness of talazoparib for patients with germline BRCA1/2 mutated HER2-negative advanced breast cancer in China and the US by Junjie Pan, Ning Ren, Lanqi Ren, YiBei Yang, Qiaoping Xu

Get full text

46, XX disorder of sexual development associated with mixed germ cell tumor of the prostate: a rare case report by Changrong Wang, Jiangli Du, Xueping Xiang, Yuyong Wang, Jingjing Xiang, Qiaoping Xu

Get full text

RNA m6A methylation regulators in liver cancer by Qiaoping Xu, Ning Ren, Lanqi Ren, Yibei Yang, Junjie Pan, Hongkai Shang

Get full text

Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1 by Feng Gao, Qiaoping Xu, Zhe Tang, Nan Zhang, Yasheng Huang, Zhongyi Li, Yuliang Dai, Qiqi Yu, Jingyu Zhu

Get full text

The emerging role of glycolysis and immune evasion in ovarian cancer by Bowen Jin, Zehua Miao, Junjie Pan, Zhen Zhang, Yibei Yang, Yidong Zhou, Yuanxiang Jin, Zheng Niu, Qiaoping Xu

Get full text

Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china by Qiaoping Xu, Li Yuanyuan, Zhu Jiejing, Liu Jian, Li Qingyu, Chen Lingya, Luo Ying, Shi Changchen, Li Yangling, Yan Wei

Get full text